22 positive Ieukemic ceI IIi ne . Recurrence of the same patient as NALM-20 .

22
positive Ieukemic ceI IIi ne .
Recurrence of the same
patient as NALM-20 . Struktur
CAS-Nr.
Englisch Name:
22 positive Ieukemic ceI IIi ne . Recurrence of the same patient as NALM-20 .
Synonyma:
22 (q34;22 positive Ieukemic ceI IIi ne .;Bi phenotypic (B-ceII and myeIoid ceII features)t(9;22 positive Ieukemic ceI IIi ne . Recurrence of the same patient as NALM-20 .;q11)-positive B-ceII precursor ceIIIi ne estabI ish from acute Ieukemia patient;22 positive acute IymphobIastic Ieukemia ceIII ine . Fromthe same patient as NALM-25;22 positive acute IymphobIastic Ieukemia ceIII ine . Derived fromthe same patient as NALM-24
CBNumber:
CB221457379
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

22 positive Ieukemic ceI IIi ne . Recurrence of the same patient as NALM-20 . Eigenschaften

Sicherheit

22 positive Ieukemic ceI IIi ne . Recurrence of the same patient as NALM-20 . Chemische Eigenschaften,Einsatz,Produktion Methoden

22 positive Ieukemic ceI IIi ne . Recurrence of the same patient as NALM-20 . Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


22 positive Ieukemic ceI IIi ne . Recurrence of the same patient as NALM-20 . Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Guangzhou Fu'erbo Biological Technology Co.,Ltd. 19513720913
1536198927@qq.com China 10000 58

  • 22 positive Ieukemic ceI IIi ne . Recurrence of the same patient as NALM-20 .
  • Bi phenotypic (B-ceII and myeIoid ceII features)t(9
  • 22 positive Ieukemic ceI IIi ne .
  • 22 (q34
  • q11)-positive B-ceII precursor ceIIIi ne estabI ish from acute Ieukemia patient
  • 22 positive acute IymphobIastic Ieukemia ceIII ine . Fromthe same patient as NALM-25
  • 22 positive acute IymphobIastic Ieukemia ceIII ine . Derived fromthe same patient as NALM-24
Copyright 2019 © ChemicalBook. All rights reserved